Charles River Laboratories
630 hedge funds and large institutions have $12.4B invested in Charles River Laboratories in 2023 Q4 according to their latest regulatory filings, with 93 funds opening new positions, 203 increasing their positions, 257 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.2% more ownership
Funds ownership: 101.04% → 102.24% (+1.2%)
21% less repeat investments, than reductions
Existing positions increased: 203 | Existing positions reduced: 257
32% less call options, than puts
Call options by funds: $54.7M | Put options by funds: $80.5M
Holders
630
Holding in Top 10
8
Calls
$54.7M
Puts
$80.5M
Top Buyers
| 1 | +$99M | |
| 2 | +$96.6M | |
| 3 | +$72.7M | |
| 4 |
MG
Meritage Group
San Francisco,
California
|
+$64.2M |
| 5 |
SCA
Southpoint Capital Advisors
New York
|
+$47.3M |
Top Sellers
| 1 | -$124M | |
| 2 | -$65.7M | |
| 3 | -$56.1M | |
| 4 |
CI Investments Inc
Toronto,
Ontario, Canada
|
-$42.6M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$34M |